{"entity":{"type":"insider","cik":"0001476315","url":"/insider/0001476315","json_url":"/insider/0001476315.json","name":"Neumayer Matthew Paul","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":4,"n_filings":4,"first":"2013-08-20","last":"2014-05-30","span_basis":"filed_date"},"name_variants":[{"name":"Neumayer Matthew Paul","source":"filing","n_filings":4,"first_seen":"2013-08-20","last_seen":"2014-05-30"}],"transactions":[{"id":6428595,"accession":"0001179110-14-009419","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-14-009419","line_url":"/filing/0001179110-14-009419#line-1","is_derivative":false,"issuer_cik":"0001360886","issuer_name":"OSIRIS THERAPEUTICS, INC.","issuer_ticker":"OSIR","issuer_name_source":null,"issuer_url":"/issuer/0001360886","owner_cik":"0001476315","owner_name":"Neumayer Matthew Paul","owner_display_name":"Neumayer Matthew Paul","owner_url":"/insider/0001476315","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common STock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":15.55,"price_display":"15.55","price_state":"stated","total_value":7775.0,"total_display":"7,775.00","total_whole":"7,775","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-29","filed_date":"2014-05-30","scope":"insider"},{"id":9242098,"accession":"0001179110-14-009418","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-14-009418","line_url":"/filing/0001179110-14-009418#line-1","is_derivative":false,"issuer_cik":"0001360886","issuer_name":"OSIRIS THERAPEUTICS, INC.","issuer_ticker":"OSIR","issuer_name_source":null,"issuer_url":"/issuer/0001360886","owner_cik":"0001476315","owner_name":"Neumayer Matthew Paul","owner_display_name":"Neumayer Matthew Paul","owner_url":"/insider/0001476315","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3750.0,"shares_display":"3,750","price_per_share":16.1,"price_display":"16.10","price_state":"stated","total_value":60375.0,"total_display":"60,375.00","total_whole":"60,375","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-27","filed_date":"2014-05-30","scope":"insider"},{"id":6827936,"accession":"0001179110-14-009316","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001179110-14-009316","line_url":"/filing/0001179110-14-009316#line-5","is_derivative":false,"issuer_cik":"0001360886","issuer_name":"OSIRIS THERAPEUTICS, INC.","issuer_ticker":"OSIR","issuer_name_source":null,"issuer_url":"/issuer/0001360886","owner_cik":"0001476315","owner_name":"Neumayer Matthew Paul","owner_display_name":"Neumayer Matthew Paul","owner_url":"/insider/0001476315","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3750.0,"shares_display":"3,750","price_per_share":16.1,"price_display":"16.10","price_state":"stated","total_value":60375.0,"total_display":"60,375.00","total_whole":"60,375","shares_owned_after":5875.0,"shares_owned_after_display":"5,875","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-27","filed_date":"2014-05-29","scope":"insider"},{"id":5063099,"accession":"0001179110-13-013312","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-13-013312","line_url":"/filing/0001179110-13-013312#line-1","is_derivative":false,"issuer_cik":"0001360886","issuer_name":"OSIRIS THERAPEUTICS, INC.","issuer_ticker":"OSIR","issuer_name_source":null,"issuer_url":"/issuer/0001360886","owner_cik":"0001476315","owner_name":"Neumayer Matthew Paul","owner_display_name":"Neumayer Matthew Paul","owner_url":"/insider/0001476315","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common STock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11375.0,"shares_display":"11,375","price_per_share":19.75,"price_display":"19.75","price_state":"stated","total_value":224656.25,"total_display":"224,656.25","total_whole":"224,656","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-08-20","filed_date":"2013-08-20","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":4,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":4,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":4},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001360886","name":"OSIRIS THERAPEUTICS, INC.","url":"/issuer/0001360886","role":"Officer (Principal Accounting Officer)","n_filings":4,"first_seen":"2013-08-20","last_seen":"2014-05-30"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001476315","retrieved_at":"2026-08-24T04:00:55+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}